Prashant Nambiar

Dr. Prashant Nambiar is the Chief Scientific Officer at Strand Therapeutics and brings more than two decades of experience leading research, preclinical development, and translational programs across biotechnology and pharmaceutical industries. At Strand, Dr. Nambiar oversees the company’s Research and Preclinical development organization, spanning mRNA discovery, synthetic biology, pharmacology, automation, computational biology, and nonclinical safety. He has been instrumental in advancing Strand’s pipeline of programmable mRNA medicines, including its first self-replicating mRNA therapeutic now in clinical development.